JPAG Symposium: Stability VI

The MTS consultant, Oona McPolin, will deliver a presentation entitled, ‘Challenges in Development and Validation of Stability Indicating Methodology‘ at the JPAG symposium, ‘Stability VI’ on the 30th June 2022, which will be held at the Royal Society of Chemistry in Burlington House, London. If you are interested in the analytical methodology used for supporting stability programmes then you might like to come along. The details of the symposium are provided below.

TITLE OF EVENT:

Stability VI

DATE OF EVENT:

Thursday 30th June 2022

SYNOPSIS OF EVENT:

“Continuing our successful series of stability meetings, this event is essential for anyone with an interest in the management and assessment of drug stability.

  • Hear about the regulations and the basics of setting up stability studies.
  • Learn from industry experts about the challenges and practical issues they face in stability work.
  • Hear about case studies and join in with the workshop based hypothetical examples.
  • Examine the basics of stability testing and learn about method development – are your methods stability indicating?”
EVENT LINK:

https://www.jpag.org/155

VENUE:

Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BA

VENUE LINK:

www.rsc.org/locations-contacts/

ORGANISED BY:

Joint Pharmaceutical Analysis Group

WEB LINK:

https://www.jpag.org/

SPONSORS:

Royal Pharmaceutical Society and Royal Society of Chemistry

CONTACT:

Hon Events Secretary JPAG, events@jpag.org

SPEAKERS:

Miles Ambler – GlaxoSmithKline
Dr Touraj Ehtezazi – Liverpool John Moores University
Dr Lisa Hinchliffe – LangAllan CMC Regulatory Solutions
John McDermott – Quotient Sciences
Oona McPolin – Mourne Training Services
Laima Ozolina – Biopharma Stability Testing Laboratory Ltd.
Dr Maxine Palmer – AstraZeneca
Dr Alan Wilkinson – Biopharma Stability Testing Laboratory Ltd

Related content from our Resources Library
Limit of Quantitation: Does it Matter?
Defined as "the  lowest amount of analyte  in a  sample which  can be quantitatively determined with  suitable precision and  accuracy" …
Drafts of ICH Q2(R2) and Q14 on Public Consultation
Draft versions of the revision of ICH Q2, Validation of Analytical Procedures, and also the new guideline Q14, Analytical Procedure …
How Much Forced Degradation in a Stress Study?
Question: When I forcibly degrade my drug or drug product to create degradation products, how much degradation should I aim …
Services related to this content that we offer

The topics of developing and validating stability indicating analytical methods is included in our courses, ‘How to Develop Stability Indicating HPLC Methods‘, and ‘Validation, Verification and Transfer of Methods for Pharmaceutical Analysis‘.

Visit our courses page for a full list of available courses and the schedule of currently available course dates.